MedPath

Botulinum toxin type B

Generic Name
Botulinum toxin type B
Brand Names
Myobloc
Drug Type
Biotech
CAS Number
93384-44-2
Unique Ingredient Identifier
0Y70779M1F

Overview

Neurotoxin produced by fermentation of clostridium botulinum type B. The protein exists in noncovalent association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin complex. The neurotoxin complex is recovered from the fermentation process and purified through a series of precipitation and chromatography steps.

Background

Neurotoxin produced by fermentation of clostridium botulinum type B. The protein exists in noncovalent association with hemagglutinin and nonhemagglutinin proteins as a neurotoxin complex. The neurotoxin complex is recovered from the fermentation process and purified through a series of precipitation and chromatography steps.

Indication

For the treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia.

Associated Conditions

  • Cervical Dystonia
  • Chronic Sialorrhea

FDA Approved Products

Myobloc
Manufacturer:Solstice Neurosciences, LLC
Route:INTRAMUSCULAR
Strength:2500 [USP'U] in 0.5 mL
Approved: 2023/12/20
NDC:10454-710
Myobloc
Manufacturer:Solstice Neurosciences, LLC
Route:INTRAMUSCULAR
Strength:10000 [USP'U] in 2 mL
Approved: 2023/12/20
NDC:10454-712
Myobloc
Manufacturer:Solstice Neurosciences, LLC
Route:INTRAMUSCULAR
Strength:5000 [USP'U] in 1 mL
Approved: 2023/12/20
NDC:10454-711

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath